Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S announced an update on its share repurchase program. The company initiated a new share repurchase program on May 6, 2026, under which it plans to repurchase B shares up to DKK 11,200,000,010.45 between May 6, 2026, and February 1, 2027. This is part of a larger program to repurchase up to DKK 15 billion over a 12-month period starting February 4, 2026. Between May 6 and May 13, 2026, the company repurchased 1,239,849 B shares for a total value of DKK 369,728,627. Additionally, transactions related to incentive programs resulted in a net transfer of 204,498 shares. As of May 13, 2026, Novo Nordisk holds 33,184,329 B shares as treasury shares, representing 0.7% of the share capital. Since February 4, 2026, the company has repurchased a total of 15,999,028 B shares, with a transaction value of DKK 4,169,728,617.